✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Gujarat Terce Laboratories Ltd.

GUJTERC

Market Cap
₹27 Cr.
P/E
12.19

Gujarat Terce Laboratories Ltd.

  • Gujarat Terce Labs.
  • Unick Fix-A-Form
  • Medistep Healthcare

FAQs on Gujarat Terce Laboratories Ltd. Shareprice

Gujarat Terce Labs. has given lower returns compared to its competitors.
Gujarat Terce Labs. has grown at ~-32.73% over the last 1yrs while peers have grown at a median rate of -31.0%

Gujarat Terce Labs. is not expensive.
Latest PE of Gujarat Terce Labs. is 12.19, while 3 year average PE is 21.18.
Also latest EV/EBITDA of Gujarat Terce Labs. is 6.79 while 3yr average is 52.34.

View FAQ's On Business

Growth Table

  • Gujarat Terce Laboratories Ltd.
  • Unick Fix-A-Form
  • Medistep Healthcare

Balance Sheet

  • Gujarat Terce Laboratories Ltd.
  • Unick Fix-A-Form
  • Medistep Healthcare

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Gujarat Terce Laboratories Ltd.
  • Unick Fix-A-Form
  • Medistep Healthcare

Cash Flow

  • Gujarat Terce Laboratories Ltd.
  • Unick Fix-A-Form
  • Medistep Healthcare

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Gujarat Terce Laboratories Ltd.
  • Unick Fix-A-Form
  • Medistep Healthcare

Quarterly Results

  • Gujarat Terce Laboratories Ltd.
  • Unick Fix-A-Form
  • Medistep Healthcare

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Gujarat Terce Laboratories Ltd. Financials

Balance sheet of Gujarat Terce Labs. is strong.
But short term working capital might become an issue for this company.

The net debt of Gujarat Terce Labs. is decreasing.
Latest net debt of Gujarat Terce Labs. is -₹1.56 Crs as of Mar-26.
This is less than Mar-25 when it was -₹0.55 Crs.

The profit is oscillating.
The profit of Gujarat Terce Labs. is ₹2.22 Crs for TTM, -₹0.98 Crs for Mar 2025 and ₹0.24 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gujarat Terce Labs. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech